Skip to main content
Premium Trial:

Request an Annual Quote

Kinaxo Receives European Patent for Chemical Proteomics Technology


This story originally ran on April 12.

Kinaxo Biotechnologies said this week it has been granted a European patent covering its proteomics technology.

Entitled "Proteome-wide quantification of small molecule binding to cellular target proteins," the patent encompasses the company's Cellular Target Profiling, KinAffinity, and Epigenetics Target Profiling services.

Kinaxo's KinAffinity and Epigenetics Target products combine chemical proteomics methods with quantitative mass spectrometry to generate target selectivity data for kinase inhibitors and epigenetic drugs, respectively. The Cellular Target Profiling service offers analysis of potential off-target interactions for compounds across the proteome of a given cell line or tissue sample.

Such data "significantly supports decision-making at various stages of the drug development process," said Henrik Daub, Kinaxo's chief technology officer, in a statement.

The company, which drug developer Evotec agreed in February to purchase for up to €16 million ($22 million) in cash and stock (GWDN 02/09/2011), has inked a number of deals in recent months for the use of its technology, with customers including pharmaceutical firms like Takeda (PM 03/18/2011), AstraZeneca (PM 01/07/2011), and Bristol-Myer Squibb (GWDN 10/11/2010).

Patent applications for the technology are pending in the United States and Japan, Kinaxo said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.